flexopharm® GmbH & Co. KG was founded in August 2007 by the dermatologist Dr. Ulrich Matthes to develop and market drugs. From the beginning our company has had a manufacturing permit according to § 13 AMG.
Since 2015 we provide our knowledge and years of experience in drug development and conduct of clinical trials to other companies by undertaking legal representative roles and CRO activities. In the same year we stopped developing own drug.
Currently we act as a service provider for all questions regarding clinical trials and drugs development. We do this in close and trustful co-operation with clients, co-operational service providers, scientific partners and authorities.